The shoulder system received FDA clearance in March, and a commercial launch is planned for later this year, according to the May 5 news release. The single-tray arthroplasty system maximizes efficiency and bone preservation, Catalyst said.
“These first surgeries with our Archer R1 reverse system went well, and we’re excited by the feedback we’re getting from the initial surgeon users,” Catalyst chair and CEO Brian Hutchinson said.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
